Related Experiment Video

Updated: May 13, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

Cardiac lipotoxicity: molecular pathways and therapeutic implications

Konstantinos Drosatos1, P Christian Schulze

  • 1Division of Preventive Medicine and Nutrition, Department of Medicine, Columbia University College of Physicians & Surgeons, 630 West 168th Street, New York, NY 10032, USA. kd2277@columbia.edu

Current Heart Failure Reports
|March 20, 2013
PubMed

Insights

Diabetes and obesity can cause lipotoxic cardiomyopathy, a heart condition linked to toxic lipid accumulation. This occurs due to a metabolic shift favoring fatty acid over glucose use, damaging heart cells.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Toxicology

Background:

  • Diabetes and obesity are linked to lipotoxic cardiomyopathy, a heart condition separate from coronary artery disease and hypertension.
  • Lipotoxicity is a growing public health issue contributing significantly to clinical cardiac disease.
  • Cellular abnormalities may arise from a metabolic shift towards increased fatty acid oxidation and decreased glucose oxidation, leading to toxic lipid buildup.

Purpose of the Study:

  • To explore the mechanisms by which lipotoxicity contributes to cardiomyopathy in diabetes and obesity.
  • To identify the specific lipids and cellular pathways involved in lipotoxic cardiac damage.

Main Methods:

  • Review of recent scientific data and literature on lipotoxicity and cardiac disease.
  • Analysis of cellular and molecular mechanisms implicated in lipotoxic cardiomyopathy.

Main Results:

  • Fatty acids, fatty acyl coenzyme A, diacylglycerol, and ceramide are implicated in cellular lipotoxicity.
  • Lipotoxicity can manifest through apoptosis, impaired insulin signaling, endoplasmic reticulum stress, protein kinase C activation, MAPK activation, and PPAR modulation.

Conclusions:

  • Metabolic dysregulation in diabetes and obesity can lead to lipotoxic cardiomyopathy.
  • Understanding these mechanisms is crucial for developing therapeutic strategies to prevent or treat lipotoxic cardiac damage.

Related Concept Videos

Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...